Statins decrease all-cause mortality only in CKD patients not requiring dialysis therapy--a meta-analysis of 11 randomized controlled trials involving 21,295 participants.

Statins decrease all-cause mortality only in CKD patients not requiring dialysis therapy--a meta-analysis of 11 randomized controlled trials involving 21,295 participants.

Item
http://www.wikidata.org/entity/Q34642771
Lipid, blood pressure and kidney update 2013.Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel.Contrasting Cholesterol Management Guidelines for Adults with CKD.Association between higher rates of cardioprotective drug use and survival in patients on dialysisBiphasic Regulation of Lipid Metabolism: A Meta-Analysis of Icodextrin in Peritoneal Dialysis.Efficacy of Statin Treatment in Early-Stage Chronic Kidney DiseaseStatin treatment in the elderly: how much do we know?Association between metabolic syndrome and chronic kidney disease in perimenopausal womenEligibility for Statin Treatment in Korean Subjects with Reduced Renal Function: An Observational Study.Treatment of non-ST-elevation myocardial infarction and ST-elevation myocardial infarction in patients with chronic kidney disease.Effects of statins-use for patients with aneurysmal subarachnoid hemorrhage: a meta-analysis of randomized controlled trials.Statins in chronic kidney disease: cardiovascular risk and kidney function.Lipid mediators in diabetic nephropathy.Should we use statins in all patients with chronic kidney disease without dialysis therapy? The current state of knowledge.Dyslipidemia in Dialysis Patients.Statins can improve proteinuria and glomerular filtration rate loss in chronic kidney disease patients, further reducing cardiovascular risk. Fact or fiction?Treatment options for dyslipidemia in chronic kidney disease and for protection from contrast-induced nephropathy.Combination drug versus monotherapy for the treatment of autosomal dominant polycystic kidney disease.New perspectives on CKD-induced dyslipidemia.Mechanisms and consequences of carbamoylation.Dyslipidaemia in the elderly: to treat or not to treat?Meta-analysis of lipid-lowering therapy in maintenance dialysis patients.
P2860
Q33574532-DF2689B5-7F53-4679-B0EA-3D42B11C356BQ35232279-BE38CD68-1C59-46A0-9977-E349EBD597DEQ35550614-BF5CE65C-5DAC-4BFE-A00C-0863CFCE0FDBQ35812557-8ADE7DDD-0D0C-47DE-8171-0C4B924E94B5Q35898688-DEBF3980-53A4-4E9F-91DC-5005C0D54E87Q36247899-24FF52CD-5C8D-495D-A2A3-BB98F687EA69Q37180162-FBBBEC7A-AC5A-483D-A426-F52F1C91E914Q37236975-2C785A20-340A-489A-AF49-3CEE2C918B02Q37316017-137192B5-AF90-41FE-BC95-C627DB2ED259Q37517937-A29309FC-36BB-400D-9BF7-223F1878B087Q37738108-B1625226-4367-4CD1-B9B4-2A161FF8D126Q38176142-334C7AA5-EBA4-4134-9E65-4EE086F8B35FQ38248011-59F04BF6-EF56-47A9-8DA5-ABACC67DC783Q38372669-978BA956-4B3A-463A-B561-20CF878FDDBEQ38412228-BF6021CB-15E7-4B34-88A9-A2B218E3D5C4Q38513740-D65253B4-0E86-4246-8449-A11F9A6C3626Q38553332-D3BA28A6-97E3-4990-834A-EE98CFB86EDBQ38960067-83168AAF-A025-40CE-837F-92949A7C47DAQ47922360-818F10E6-5F30-4046-B773-71FB2B805B74Q48010750-F12A1C96-727B-4E12-A8C9-1A712482E506Q50180407-D4BBBF8E-15C1-4455-ACA6-EE61F307498DQ54342044-8381A1A8-C014-4B78-9FB3-5371B158DE4C
P2860

Statins decrease all-cause mortality only in CKD patients not requiring dialysis therapy--a meta-analysis of 11 randomized controlled trials involving 21,295 participants.

Item
http://www.wikidata.org/entity/Q34642771
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Statins decrease all-cause mor ...... involving 21,295 participants.
@ast
Statins decrease all-cause mor ...... involving 21,295 participants.
@en
Statins decrease all-cause mor ...... involving 21,295 participants.
@nl
type
label
Statins decrease all-cause mor ...... involving 21,295 participants.
@ast
Statins decrease all-cause mor ...... involving 21,295 participants.
@en
Statins decrease all-cause mor ...... involving 21,295 participants.
@nl
prefLabel
Statins decrease all-cause mor ...... involving 21,295 participants.
@ast
Statins decrease all-cause mor ...... involving 21,295 participants.
@en
Statins decrease all-cause mor ...... involving 21,295 participants.
@nl
P1433
P1476
P2093
P304
P31
P356
P478
P50
P577
P5875
P698
P921
P356
P1433
P1476
Statins decrease all-cause mor ...... involving 21,295 participants.
@en
P2093
P304
P31
P356
10.1016/J.PHRS.2013.03.007
P478
P50
P577
P5875
P698
P921